Pharming PHAR
NASDAQ PHAR
$9.99 -0.02 (-0.20%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pharming (PHAR) Non-Current Deferred Tax Liability (2019 - 2025)

Updated

Pharming (PHAR) reported Non-Current Deferred Tax Liability of -$31.02 million for Q4 2025, compared with -$30.54 million a year earlier.

Analysis

Pharming (PHAR) Non-Current Deferred Tax Liability (2019 - 2025) Analysis & Trends

Dating back to Q4 2019, Pharming's Non-Current Deferred Tax Liability record includes 7 quarters.

  • By year, Non-Current Deferred Tax Liability came in at -$30.54 million in FY2024, -$8.1 million in FY2023, -$6.24 million in FY2022 and -$5.81 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pharming 700.98 Mn -129.18 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -31.02 Mn
Dec 31, 2024 -30.54 Mn
Dec 31, 2023 -8.10 Mn
Dec 31, 2022 -6.24 Mn
Dec 31, 2021 -5.81 Mn
Dec 31, 2020 -1.81 Mn
Dec 31, 2019 -2.59 Mn
API Access

Pharming Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=PHAR&period=max&api_key=YOUR_API_KEY